<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1392">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05143034</url>
  </required_header>
  <id_info>
    <org_study_id>TSMH No.18-148-A</org_study_id>
    <nct_id>NCT05143034</nct_id>
  </id_info>
  <brief_title>the Evaluation of the Efficacy of TCI66207 on the Skin.</brief_title>
  <official_title>Evaluation of Skin Efficacy of TCI66207</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TCI Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TCI Co., Ltd.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to explore the evaluation of the efficacy of TCI66207 deep-sea&#xD;
      live-face bacteria on the skin.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">November 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change of skin moisture</measure>
    <time_frame>Subjects will be tested in the 4th week.</time_frame>
    <description>Corneometer® CM825 was utilized to measure skin moisture. Units: arbitrary Corneometer® units 0-120</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of skin elasticity</measure>
    <time_frame>Subjects will be tested in the 4th week.</time_frame>
    <description>Cutometer® dual MPA 580 was utilized to measure skin elasticity (parameter R2). Units: μm penetration depth into the probe opening, expressed as curvesCorneometer® units 0-120</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of skin wrinkles</measure>
    <time_frame>Subjects will be tested in the 4th week.</time_frame>
    <description>VISIA Complexion Analysis System was utilized to measure wrinkles. Units: arbitrary units</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of skin collagen density</measure>
    <time_frame>Subjects will be tested in the 4th week.</time_frame>
    <description>DermaLab® USB - 20 MHz High Freq. Ultrasound probe was utilized to scan and analyze skin collagen density. Units: Intensity score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of skin texture</measure>
    <time_frame>Subjects will be tested in the 4th week.</time_frame>
    <description>VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of skin pores</measure>
    <time_frame>Subjects will be tested in the 4th week.</time_frame>
    <description>VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Skin Diseases</condition>
  <arm_group>
    <arm_group_label>TCI66207 Essence</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Essence</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Essence</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>TCI66207 Essence</intervention_name>
    <description>Use it twice a day after washing your face in the morning and evening for a total of 4 weeks.</description>
    <arm_group_label>TCI66207 Essence</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo Essence</intervention_name>
    <description>Use it twice a day after washing your face in the morning and evening for a total of 4 weeks.</description>
    <arm_group_label>Placebo Essence</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Healthy volunteers aged above 20 years old&#xD;
&#xD;
          2. Subject has dull skin.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. .Subject with diseases of the skin, heart, liver, kidney, endocrine and other organs&#xD;
             and patients with mental illness (according to medical history).&#xD;
&#xD;
          2. Subjects who have known cosmetic, drug or food allergies, difficulty in digestive&#xD;
             tract absorption or disorder.&#xD;
&#xD;
          3. Female who is pregnant or nursing or planning to become pregnant during the course of&#xD;
             the study.&#xD;
&#xD;
          4. Received facial laser therapy, chemical peeling or UV overexposure in the past 4&#xD;
             weeks.&#xD;
&#xD;
          5. Subjects who have large spots (area &gt;3 square centimeter) or abnormal acne.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chia-Hua Liang, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chia Nan University of Pharmacy &amp; Science</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research &amp; Design Center, TCI CO., Ltd</name>
      <address>
        <city>Taipei</city>
        <state>Neipu Township</state>
        <zip>114</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 22, 2021</study_first_submitted>
  <study_first_submitted_qc>November 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2021</study_first_posted>
  <last_update_submitted>December 6, 2021</last_update_submitted>
  <last_update_submitted_qc>December 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

